CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
David J. Friedman(Broad Institute), Simon C. Robson(Beth Israel Deaconess Medical Center), Keiichi Enjyoji(Beth Israel Deaconess Hospital), Yousif I. A-Rahim(University of Hawaii System), Beat Künzli(Beth Israel Deaconess Medical Center), Eva Csizmadia(Beth Israel Deaconess Medical Center), Pascal O. Berberat(Technical University of Munich), Helmut Frieß(TUM Klinikum), Jean Sévigny(Université Laval)
Cited by 284
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856